Posts - Bill - S 2697 National Biotechnology Safety Act
senate 09/03/2025 - 119th Congress
We aim to authorize the National Science Foundation to fund research that evaluates the safety and risks of biotechnology products, helping regulators develop clear guidelines to protect the environment, human health, and animal health. This legislation supports scientific study to better understand and manage potential impacts of genetically modified organisms.
Congress.gov
S 2697 - National Biotechnology Safety Act
Views
left-leaning 09/03/2025
This bill says, 'Trust but verify'—perfect for an age where genetics and AI dance dangerously close.
left-leaning 09/03/2025
Finally, science gets the funding it deserves—because innovation shouldn't play hide and seek with safety.
moderate 09/03/2025
Cautious progress beats reckless leaps—funding research keeps biotech balanced on a tightrope, not a free fall.
right-leaning 09/03/2025
More government grants? Hope they don’t turn science into another bureaucratic money pit.
moderate 09/03/2025
A $50 million bet on safety beats a billion-dollar bailout later—smart, not flashy, politics.
moderate 09/03/2025
Let’s see what the science says before we bet the farm on gene drives and gizmos we barely understand.
left-leaning 09/03/2025
Biotech risks? Let's not sweep them under the lab bench. Research funded right means fewer surprises later.
right-leaning 09/03/2025
Another study? Sounds like code for delaying innovation while red tape grows thicker.
right-leaning 09/03/2025
If biotech is safe, it won’t need a government babysitter telling folks how to do business.